Catalog No.
DHB10202
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Human
Isotype
IgG2-kappa
Clonality
Monoclonal
Target
B7RP1, B7-related protein 1, CD275, ICOSL, ICOSLG, KIAA0653, B7 homolog 2, ICOS ligand, B7RP-1, B7H2, B7-H2, B7-like protein Gl50, BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived TNF-like molecule, TALL-1, TNF- and APOL-related leukocyte expressed ligand 1, BLyS, B lymphocyte stimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activating factor
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
O75144 & Q9Y275
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
CAS: 2143449-47-0
Clone ID
Rozipafusp alfa
Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation, PMID: 31807265
Dornase alfa for cystic fibrosis, PMID: 30187450
Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia: A Randomized, Double-Blind, Phase 3 Trial, PMID: 32723804
Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease, PMID: 29921734
Dornase Alfa, PMID: 32310478
Dornase alfa (Pulmozyme), PMID: 22990660
Lutropin alfa, PMID: 18627209
A pharmacokinetic evaluation of ropeginterferon alfa-2b in the treatment of polycythemia vera, PMID: 33118413
Epoetin Alfa, PMID: 30000431
Asfotase alfa for hypophosphatasia, PMID: 30670890
Susoctocog Alfa: A Review in Acquired Haemophilia A, PMID: 27098420
Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent, PMID: 30813754
Interference of Asfotase Alfa in Immunoassays Employing Alkaline Phosphatase Technology, PMID: 32445383
Darbepoetin alfa, PMID: 11735636
Efmoroctocog alfa for haemophilia A, PMID: 30670892
Octocog alfa, plasma/albumin-free method, PMID: 16392876
Peginterferon Alfa, PMID: 29999705
XM17 Follitropin Alfa (Ovaleap(®)): A Review in Reproductive Endocrine Disorders, PMID: 27342604
Vestronidase Alfa, PMID: 30000015
Dornase alfa for cystic fibrosis, PMID: 27043279
Ropeginterferon alfa-2 b for the therapy of polycythemia vera, PMID: 32942868
Dornase Alfa, PMID: 29999662
Alglucosidase Alfa, PMID: 30000880
Trenonacog alfa for prophylaxis, on-demand and perioperative management of hemophilia B, PMID: 29172774
Turoctocog alfa (NovoEight®)--from design to clinical proof of concept, PMID: 24797664
Dornase Alfa for Non-Cystic Fibrosis Pediatric Pulmonary Atelectasis, PMID: 24811400
Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 disease, PMID: 31363309
Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A, PMID: 25848213
Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology, PMID: 24630271
Sebelipase alfa: enzymatic replacement treatment for lysosomal acid lipase deficiency, PMID: 27376161
Interferon-alfa in the treatment of chronic hepatitis B, PMID: 15313664
Darbepoetin alfa: a novel erythropoiesis-stimulating protein, PMID: 12973399
Spotlight on taliglucerase alfa in the treatment of pediatric patients with type 1 Gaucher disease, PMID: 29388611
Agalsidase alfa: a review of its use in the management of Fabry disease, PMID: 22946754
Pharmacology of darbepoetin alfa, PMID: 17526547
Darbepoetin alfa: in patients with chemotherapy-related anaemia, PMID: 12749734
Interview with Dr Ghassan K Abou-Alfa, PMID: 27993088
Darbepoetin alfa: a novel erythropoiesis-stimulating protein, PMID: 12086553
Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction, PMID: 21815699
Peginterferon alfa-2a: a review of approved and investigational uses, PMID: 15336466
Epoetin alfa. Clinical evolution of a pleiotropic cytokine, PMID: 14769622
Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease, PMID: 29471850
Stability of Turoctocog Alfa, a Recombinant Factor VIII Product, during Continuous Infusion In Vitro, PMID: 33195971
Epoetin alfa in cancer patients: evidence-based guidelines, PMID: 11728799
Epoetin alfa versus darbepoetin alfa in chemotherapy-related anemia, PMID: 16332942
Real-world utilization of darbepoetin alfa in cancer chemotherapy patients, PMID: 28814194
Epoetin alfa as a supportive measure in hematologic malignancies, PMID: 12447849
Dornase alfa, PMID: 18031106
Darbepoetin alfa: a new approach to the treatment of chemotherapy-induced anaemia, PMID: 12783618
Epoetin alfa use in gynecology. Past, present and future, PMID: 11396388
For research use only. Not for human or drug use.
